Zacks Small Cap Analysis – MDXG: Closing Be aware Earlier than Wednesday’s Earnings – Go Well being Professional

By John Vandermosten, CFA

NASDAQ:MDXG

Our protection of MiMedx Group, Inc. (NASDAQ:MDXG) during the last three- and one-half years concludes at this time. Throughout that interval, we’ve seen the corporate evolve from a analysis and development-focused firm to a money circulation producing agency in a powerful place to bolt on complementary merchandise. The steadiness sheet has improved dramatically with the $100 million in convertible inventory faraway from the capital construction and a money steadiness of $50 million to deploy within the pursuit of complementary belongings. With this be aware we withdraw our estimates and valuation value goal with confidence that the corporate will proceed its progress trajectory.

Since our report following first quarter earnings, MiMedx has offered some updates to buyers on its attendance at investor conferences, inside appointments, new publications and the date of its second quarter convention name.

Investor Relations

Sustaining its custom of investor communication, Mat Notarianni’s IR crew supplied up members of MiMedx’ senior administration on the Craig Hallum twenty first Annual Institutional Investor Convention and the Northland Progress Convention in the course of the months of Might and June.

➢ Craig-Hallum Institutional Investor Convention

o Wednesday, Might 29, 2024

o Minneapolis, Minnesota

➢ Northland Progress Convention

o Tuesday, June 25, 2024

o Digital

New Appointments

MiMedx appointed and promoted Kim Moller to Chief Business Officer. Ms. Moller had beforehand served as the corporate’s Senior Vice President of Gross sales since August 2020. She is going to tackle further tasks which embody advertising and worldwide business operations. Her tenure at MiMedx and former expertise at 3M subsidiaries Acelity and KCI and an MBA from Colorado Christian College offered the inspiration for this position.

Second Quarter Earnings Report Date

MiMedx introduced that its second quarter working and monetary outcomes reporting date will likely be July 31, 2024. Particulars will likely be launched after market shut that day with a convention name to comply with at 4:30 pm ET.

➢ US Traders

o (877) 407-6184

o Convention ID: 13747365

➢ Webcast hyperlink right here

New Publication

A brand new research was revealed in Nature – Scientific Experiences entitled Human amniotic membrane modulates collagen manufacturing and deposition in vitro. The article offered proof that MiMedx’ dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion/chorion membrane (LHACM) can modulate the manufacturing, secretion and deposition of collagen kind I, a major goal for pathological fibrosis. The result’s a discount in pathological fibrosis and a prophylactic therapy to counteract fibrotic processes that come from the usage of amniotic membrane allografts. A abstract of the article and associated administration commentary may be discovered within the July twenty second press launch.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to obtain our articles and studies emailed on to you every morning. Please go to our web site for extra info on Zacks SCR. 

DISCLOSURE: Zacks SCR has acquired compensation from the issuer immediately, from an funding supervisor, or from an investor relations consulting agency, engaged by the issuer, for offering analysis protection for a interval of at least one yr. Analysis articles, as seen right here, are a part of the service Zacks SCR gives and Zacks SCR receives quarterly funds totaling a most payment of as much as $40,000 yearly for these companies offered to or relating to the issuer. Full Disclaimer HERE.